Trepibutone is a drug used for functional gastrointestinal disorders.[1] Trepibutone promotes secretion of the bile and pancreatic juice, and accelerates flaccidity of the smooth muscle in the gastrointestinal tract to lower internal pressure of the gallbladder and bile duct. It improves the symptoms of the bile duct and pancreatic disease. It is usually used for improvement of cramp and bile secretion associated with cholelithiasis, cholecystitis, cholangitis, dyskinesia of the biliary tract or postcholecystectomy syndrome, or pain and gastrointestinal symptoms associated with chronic pancreatitis.[2]
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H22O6 |
| Molar mass | 310.346 g·mol−1 |
References
edit- ^ "Trepibutone". PubChem. U.S. National Library of Medicine. Retrieved 2019-03-01.
- ^ "Trepibutone". NCATS Inxight: Drugs. National Center for Advancing Translational Sciences (NCATS). Retrieved 2019-03-01.
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |